User profiles for Michael J. Pikal

Michael J. Pikal

Eli Lilly, University of Connecticut, UCONN
Verified email at uconn.edu
Cited by 22567

Design of freeze-drying processes for pharmaceuticals: practical advice

X Tang, MJ Pikal - Pharmaceutical research, 2004 - Springer
Abstract Design of freeze-drying processes is often approached with a “trial and error”
experimental plan or, worse yet, the protocol used in the first laboratory run is adopted without …

Rational design of stable lyophilized protein formulations: some practical advice

JF Carpenter, MJ Pikal, BS Chang… - Pharmaceutical …, 1997 - search.proquest.com
Early in the development of a protein therapeutic it is essential to design a formulation that
is stable during shipping and long-term storage. Obviously, an aqueous liquid formulation is …

Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally …

SB Murdande, MJ Pikal, RM Shanker… - Pharmaceutical …, 2010 - Springer
Purpose To quantitatively assess the solubility advantage of amorphous forms of nine insoluble
drugs with a wide range of physico-chemical properties utilizing a previously reported …

Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy …

…, J Sun, D Ouellette, KL Grant, XC Tang, MJ Pikal - Journal of …, 2005 - Elsevier
The purpose of this study is to investigate the mechanism of protein stabilization by sugars in
the solid state. That is, explore whether the stabilization is controlled by “glass dynamics” or …

Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis

SB Murdande, MJ Pikal, RM Shanker… - Journal of pharmaceutical …, 2010 - Elsevier
In recent years there has been growing interest in advancing amorphous pharmaceuticals
as an approach for achieving adequate solubility. Due to difficulties in the experimental …

Characterization of the time scales of molecular motion in pharmaceutically important glasses

…, X Tang, L Chang, BC Hancock, MJ Pikal - The Journal of …, 1999 - ACS Publications
Increased interest in molecular time scales below the glass transition temperature, T g , has
arisen from the desire to identify the conditions (eg, temperature) where the molecular …

Mechanisms of protein stabilization in the solid state

LL Chang, MJ Pikal - Journal of pharmaceutical sciences, 2009 - Elsevier
The solid state is preferred for many proteins due to their marginal stability in solution. However,
even in the solid state, chemical and physical degradation can occur on the time scale …

Effect of initial buffer composition on pH changes during far-from-equilibrium freezing of sodium phosphate buffer solutions

G Gomez, MJ Pikal, N Rodríguez-Hornedo - Pharmaceutical research, 2001 - Springer
Purpose. This study aims to assess the pH changes induced by salt precipitation during far-from-equilibrium
freezing of sodium phosphate buffers as a function of buffer composition, …

Stabilization of proteins in solid form

MT Cicerone, MJ Pikal, KK Qian - Advanced drug delivery reviews, 2015 - Elsevier
Immunogenicity of aggregated or otherwise degraded protein delivered from depots or other
biopharmaceutical products is an increasing concern, and the ability to deliver stable, active …

Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state

C Bhugra, MJ Pikal - Journal of pharmaceutical sciences, 2008 - Elsevier
Though there is an advantage in using the higher solubility amorphous state in cases where
low solubility limits absorption, physical instability poses a significant barrier limiting its use …